Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Gynecology

Free Subscription Articles published in Oncogene Retrieve available abstracts of 35 articles: HTML format Text format

Single Articles

May 2012
1. SHER YP , Chang CM, Juo CG, Chen CT, et al
   Targeted endostatin-cytosine deaminase fusion gene therapy plus 5-fluorocytosine suppresses ovarian tumor growth.
   Oncogene. 2012 May 7. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
2. CHENG JC , Chang HM, Leung PC
   Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells.
   Oncogene. 2012 Apr 16. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. XU J , Li Y, Wang F, Wang X, et al
   Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
   Oncogene. 2012 Apr 2. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
4. YERAMIAN A , Moreno-Bueno G, Dolcet X, Catasus L, et al
   Endometrial carcinoma: molecular alterations involved in tumor development and progression.
   Oncogene. 2012 Mar 19. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
5. YIN G , Alvero AB, Craveiro V, Holmberg JC, et al
   Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential.
   Oncogene. 2012 Feb 20. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. SU PH , Lin YW, Huang RL, Liao YP, et al
   Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer.
   Oncogene. 2012 Feb 13. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
7. XU PZ , Chen ML, Jeon SM, Peng XD, et al
   The effect Akt2 deletion on tumor development in Pten(+/-) mice.
   Oncogene. 2012;31:518-26.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. ARCHIBALD KM , Kulbe H, Kwong J, Chakravarty P, et al
   Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium.
   Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. COLAS E , Muinelo-Romay L, Alonso-Alconada L, Llaurado M, et al
   ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.
   Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. MURA M , Swain RK, Zhuang X, Vorschmitt H, et al
    Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.
    Oncogene. 2012;31:293-305.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. JEONG KJ , Park SY, Cho KH, Sohn JS, et al
    The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. ZELLER C , Dai W, Steele NL, Siddiq A, et al
    Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.
    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
13. QIN W , Dong P, Ma C, Mitchelson K, et al
    MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.
    Oncogene. 2011 Dec 19. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. ALBERTI C , Pinciroli P, Valeri B, Ferri R, et al
    Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
    Oncogene. 2011 Dec 12. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. RATNER ES , Keane FK, Lindner R, Tassi RA, et al
    A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.
    Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
16. RAMACHANDRAN I , Thavathiru E, Ramalingam S, Natarajan G, et al
    Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Oncogene. 2011 Oct 17. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. CAO L , Shao M, Schilder J, Guise T, et al
    Tissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.
    Oncogene. 2011 Oct 3. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
18. WANG Y , Sheng Q, Spillman MA, Behbakht K, et al
    Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells.
    Oncogene. 2011 Sep 26. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. ALI AY , Abedini MR, Tsang BK
    The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation.
    Oncogene. 2011 Sep 19. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. YUE P , Zhang X, Paladino D, Sengupta B, et al
    Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.
    Oncogene. 2011 Sep 12. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
21. RICHARDS JS , Fan HY, Liu Z, Tsoi M, et al
    Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis.
    Oncogene. 2011 Aug 22. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
22. SAHA B , Adhikary A, Ray P, Saha S, et al
    Restoration of tumor suppressor p53 by differentially regulating pro- and anti-p53 networks in HPV-18-infected cervical cancer cells.
    Oncogene. 2011 Jul 18. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ZHANG Y , Cheng Y, Ren X, Zhang L, et al
    NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
    Oncogene. 2011 Jul 11. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. CHAO A , Lin CY, Lee YS, Tsai CL, et al
    Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Oncogene. 2011 Jul 4. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
25. LAU MT , Klausen C, Leung PC
    E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via beta-catenin-Egr1-mediated PTEN expression.
    Oncogene. 2011;30:2753-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. BADGWELL DB , Lu Z, Le K, Gao F, et al
    The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
27. FU G , Peng C
    Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells.
    Oncogene. 2011.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
28. REIMER D , Hubalek M, Kiefel H, Riedle S, et al
    Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer.
    Oncogene. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
29. AL-BAHLANI S , Fraser M, Wong AY, Sayan BS, et al
    P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.
    Oncogene. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
30. ZHAI Y , Iura A, Yeasmin S, Wiese AB, et al
    MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. CHENG JC , Auersperg N, Leung PC
    Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. KIM JH , Yoon S, Park M, Park HO, et al
    Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).
    Oncogene. 2011;30:1653-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
33. MULLANY LK , Fan HY, Liu Z, White LD, et al
    Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. CHAROENFUPRASERT S , Yang YY, Lee YC, Chao KC, et al
    Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
35. SOMMER G , Dittmann J, Kuehnert J, Reumann K, et al
    The RNA-binding protein La contributes to cell proliferation and CCND1 expression.
    Oncogene. 2011;30:434-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: